Dispute Over FCA Public Disclosure Bar Distributed For Conference In Supreme Court

(August 28, 2024, 1:37 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on Aug. 28 distributed for conference a petition for certiorari filed by pharmaceutical companies seeking review of the Ninth Circuit U.S. Court of Appeals’ ruling that the public disclosure bar was not triggered in a case where it reversed a district court’s dismissal of a suit accusing the companies of violating the False Claims Act (FCA) by artificially inflating drug prices....

Attached Documents

Related Sections